The tweet was deleted by the author.
But we saved everything 🙂.
Humacyte is hosting a Hands-On Simulation Lab featuring its Symvess acellular tissue engineered vessel-type (ATEV) technology today and tomorrow.
The VAM TOUCHPOINT Hands-On / SIM Lab allows participants to directly practice using these innovative vessels in a controlled environment, reflecting the company’s drive to advance real-world clinical training. Details on the specific educational modules or participant outcomes have not yet been provided. Details are being clarified.
Humacyte recently received a contract from U.S. Veterans Affairs to expand access to its Symvess acellular tissue engineered vessel, according to a previous announcement. The company is also preparing to present interim results from a women-only vascular access study at a specialized forum on June 11, 2026, as reported earlier. These developments follow ongoing efforts by Humacyte to advance the clinical use and validation of its vascular implant technologies.